| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.03 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | 0.6 | 0.03 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.12 | 0.03 |